FIELD: ophthalmology. SUBSTANCE: invention is distinguished by that known ocular drops containing sodium succinate hexahydrate (1.351 wt %), benzalkonium chloride (0.015%), and distilled water (the balance), additionally contain sodium pyruvate (0.550), riboflavin mononucleotide phosphate (0.002%), and thiamine hydrochloride (0.020%). In one of the versions of invention, ocular drops additionally contain fructose and glucose in quantities 0.100 and 0.300 g/100 ml, respectively. EFFECT: extended choice of therapeutic means. 2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OCULAR DROPS "NEOKERATONIK" | 1997 |
|
RU2127099C1 |
| EYE DROPS | 1997 |
|
RU2121825C1 |
| EYE DROPS | 1993 |
|
RU2056821C1 |
| COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
| DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
| PHARMACEUTICAL ANTIGLAUCOMA COMPOSITION | 2009 |
|
RU2402316C2 |
| EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
| METHOD FOR CATARACT TREATMENT AND EYE DROPS FOR IMPLEMENTATION THEREOF | 2016 |
|
RU2662364C2 |
| IMPROVED EYE DROPS FOR PREVENTION AND TREATMENT OF EARLY MANIFESTATIONS OF AGE-RELATED NUCLEAR CATARACT | 2020 |
|
RU2748598C1 |
| NEW EYE DROPLETS FOR CONSERVATIVE TREATMENT AND PREVENTION OF THE AGE-RELATED NUCLEAR CATARACT | 2015 |
|
RU2637875C2 |
